Our recent studies showed that deficiency in Aldh1a1, but not in Aldh1a2 and Aldh1a3, is the characteristic feature of B cell cancers in humans, especially multiple myeloma (MM) [127]. This evidence concerns the gene ALDH1A1 and AL amyloidosis.